Adults (18-65), Geriatrics (65+)
There is no publicly available rating for this medical professional for one of the following reasons:
Adults (18-65), Geriatrics (65+)
Radiation Oncology, 2002
Perelman Center for Advanced Medicine
3400 Civic Center Boulevard
Philadelphia, PA 19104
A facility of the Hospital of the University of Pennsylvania
Vyfhuis MAL, Burrows WM, Bhooshan N, Suntharalingam M, Donahue JM, Feliciano J, Badiyan S, Nichols EM, Edelman MJ, Carr SR, Friedberg J, Henry G, Stewart S, Sachdeva A, Pickering EM, Simone CB 2nd, Feigenberg SJ, Mohindra P.: Implications of Pathologic Complete Response Beyond Mediastinal Nodal Clearance With High-Dose Neoadjuvant Chemoradiation Therapy in Locally Advanced, Non-Small Cell Lung Cancer. International Journal of Radiation Oncology Biology Physics 101 (2): 445-452,2018.
Vyfhuis Melissa A L, Bhooshan Neha, Molitoris Jason, Bentzen Søren M, Feliciano Josephine, Edelman Martin, Burrows Whitney M, Nichols Elizabeth M, Suntharalingam Mohan, Donahue James, Nagib Marc, Carr Shamus R, Friedberg Joseph, Badiyan Shahed, Simone Charles B, Feigenberg Steven J, Mohindra Pranshu: Corrigendum to "Clinical outcomes of black vs. non-black patients with locally advanced non-small cell lung cancer" [Lung Cancer 114, (December 2017) 44-49]. Lung cancer (Amsterdam, Netherlands) 116 : 105,2018.
Wallace, W. C., Feigenberg, S. J., Tyer, T. N., Pope, J. F., Erickson, D., and Hasnson, J. A.: Body Weight Status, Clinical Factors, and Short-term Outcomes Among Head and Neck Radiation Oncology Patients Topics in Clinical Nutrition 33 (1): 2018.
Vyfhuis MAL, Bhooshan N, Molitoris J, Bentzen SM, Feliciano J, Edelman M, Burrows WM, Nichols EM, Suntharalingam M, Donahue J, Nagib M, Carr SR, Friedberg J, Badiyan S, Simone CB, Feigenberg SJ, Mohindra P.: Clinical outcomes of black vs. non-black patients with locally advanced non-small cell lung cancer. Lung Cancer 114 : 44-49,2017.
Nichols EM, Becker S, Hong J, Cohen RJ, Mishra MV, Citron W, Cheston SB, Niu Y, Mutaf Y, Yu CX, Feigenberg SJ: Delivery of a single fraction lumpectomy cavity boost using a novel immobilization device and treatment delivery system Proceedings of the 2017 San Antonio Breast Cancer Symposium; 2017 Dec 5-9; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2018 78 (4 Suppl): Abstract nr OT2-03-03,2017.
Diwanji TP, Molitoris JK, Chhabra AM, Snider JW, Bentzen SM, Tkaczuk KH, Rosenblatt PY, Kesmodel SB, Bellavance EC, Cohen RJ, Cheston SB, Nichols EM, Feigenberg SJ: Utilization of hypofractionated whole-breast radiation therapy in patients receiving chemotherapy: a National Cancer Database analysis. Breast Cancer Research and Treatment 165 (2): 445-453,2017.
Lin JY, Bluebond-Langner R, Choi E, Cheston S, Nichols EM, Cohen RJ, Bentzen SM, Drogula C, Kesmodel S, Bellavance E, Rosenblatt P, Tkaczuk K, Slezak S, Feigenberg SJ: Effect of reduction mammoplasty on acute radiation side effects and use of lumpectomy cavity boosts. Practical Radiation Oncology 7 (5): e299-e308,2017.
Edelman Martin J, Hu Chen, Le Quynh-Thu, Donington Jessica S, D'Souza Warren D, Dicker Adam P, Loo Billy W, Gore Elizabeth M, Videtic Gregory M M, Evans Nathaniel R, Leach Joseph W, Diehn Maximilian, Feigenberg Steven J, Chen Yuhchyau, Paulus Rebecca, Bradley Jeffrey D: Randomized Phase II Study of Preoperative Chemoradiotherapy ± Panitumumab Followed by Consolidation Chemotherapy in Potentially Operable Locally Advanced (Stage IIIa, N2+) Non-Small Cell Lung Cancer: NRG Oncology RTOG 0839. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 12 (9): 1413-1420,2017.
Hessler Lindsay K, Molitoris Jason K, Rosenblatt Paula Y, Bellavance Emily C, Nichols Elizabeth M, Tkaczuk Katherine H R, Feigenberg Steven J, Bentzen Soren M, Kesmodel Susan B: Factors Influencing Management and Outcome in Patients with Occult Breast Cancer with Axillary Lymph Node Involvement: Analysis of the National Cancer Database. Annals of surgical oncology 24 (10): 2907-2914,2017.
Vyfhuis MAL, Bhooshan N, Burrows WM, Turner M, Suntharalingam M, Donahue J, Nichols EM, Feliciano J, Bentzen SM, Badiyan S, Carr SR, Friedberg J, Simone CB 2nd, Edelman MJ, Feigenberg SJ, Mohindra P.: Oncological outcomes from trimodality therapy receiving definitive doses of neoadjuvant chemoradiation (≥60 Gy) and factors influencing consideration for surgery in stage III non-small cell lung cancer. Advances in Radiation Oncology 2 (3): 259-269,2017.
Department of Radiation OncologyPerelman Center for Advanced Medicine3400 Civic Center Blvd
Phone: (215) 662-3998
Patient appointments: 800-789-7366
Proton therapy is a non–invasive, incredibly precise cancer treatment that uses a beam of protons moving at very high speeds to destroy cancer cells.
Our experienced cancer nurses and referral staff are here to help. Call 800-789-7366 (PENN) or complete an online request.
Learn more about the benefits of translational research at Penn Medicine.